Results 211 to 220 of about 42,923 (283)

Acetazolamide per os in Decompensated Chronic Heart Failure: Randomized Multicenter Trial ORION-A. [PDF]

J Clin Med
Sabirov I, Rubanenko O, Villevalde S, Rubanenko A, Veselovskaya N, Ivanenko V, Kosheleva N, Menzorov M, Pochinka I, Protasov K, Khasanov N, Yakushin S, Medvedeva E, Duplyakov D, ORION-A Investigators.   +14 more
europepmc   +1 more source

Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD. [PDF]

Kidney Int Rep
Costes-Albrespic M, Alencar de Pinho N, Larabi IA, El Chamieh C, Laville SM, Fouque D, Laville M, Frimat L, Alvarez JC, Massy ZA, Liabeuf S, CKD-REIN Study Group.   +11 more
europepmc   +1 more source

Spontaneous diuresis in combination with furosemide stress test (SD-FST) as predictor for successful liberation from kidney replacement therapy: a prospective observational study. [PDF]

Crit Care
Weidhase L, Wille S, Foede H, Gilch F, Mende M, Scharf-Janßen C, Petros S, de Fallois J.   +7 more
europepmc   +1 more source

Efficacy of ambulatory intravenous diuresis for chronic heart failure patients: Insights from the DEA-HF trial. [PDF]

ESC Heart Fail
Gruber A, Abbo AR, Volis I, Aronson D, Girerd N, Kristensen SL, Zukermann R, Alberkant N, Sitnitsky E, Kruger A, Khasis P, Bravo E, Elad B, Levin LH, Caspi O.   +14 more
europepmc   +1 more source

Non-mechanical haemodynamic support in acute pulmonary thromboembolism: a scoping review. [PDF]

Intensive Care Med Exp
Body W, Steckle S, Haggerty A, Putt M, Coyer F, Milford EM.   +5 more
europepmc   +1 more source

Potential drug-drug interactions among hospitalised cardiac patients in Nepal: a prospective observational study. [PDF]

BMJ Open
Sah BK, Karna AK, Subedi S, Sah RK, Shrestha S, Dangi NB.   +5 more
europepmc   +1 more source

Increased Incidence and Severity of Acute Poststreptococcal Glomerulonephritis in the Czech Paediatric Population Following the COVID-19 Pandemic. [PDF]

Nephrology (Carlton)
Konopásek P, Sládková E, Skálová S, Flögelová H, Papež J, Pecková M, Buganová M, Laubová J, Lysáčková B, Lísal J, Prošek M, Urbanová I, Kolský A, Váchová M, Mallátová K, Dáňová T, Stašková L, Štarha J, Samešová M, Penglová K, Libánská L, Šenkeřík M, Ruchařová B, Smrčka V, Plačková J, Procházková L, Láchová J, Zieg J.   +27 more
europepmc   +1 more source

Prognostic impact of the acute reactiveness to intravenous administration of tolvaptan sodium phosphate in patients with acute decompensated heart failure. [PDF]

Eur Heart J Open
Ouchi S, Iwata H, Moriya S, Naito R, Takahashi N, Kasai T, Minamino T.   +6 more
europepmc   +1 more source

How much furosemide should be administered to prevent transfusion-associated circulatory overload? Results of a dose-finding study. [PDF]

Vox Sang
Rotin L, Zhang L, Armali C, Malkin A, Massin S, Meirovich H, Roque D, Saeed S, Vijenthira S, Lin Y, Pendergrast J.   +10 more
europepmc   +1 more source

Stability and physical compatibility of parenteral nalbuphine hydrochloride during continuous infusion in pediatrics. [PDF]

PLoS One
Paoli-Lombardo R, Arcani V, Dazan D, Castera-Ducros C, Esteve MA, Roudot M, Wanert C, Ovaert C, Curti C, Vanelle P, Rathelot P.   +10 more
europepmc   +1 more source